Differential Expression of mRNA Encoding Cytokines and Chemokines in the Reproductive Tract after Infection of Mice with \u3cem\u3eChlamydia trachomatis\u3c/em\u3e by Cerny, Katheryn L. et al.
University of Kentucky
UKnowledge
Animal and Food Sciences Faculty Publications Animal and Food Sciences
9-9-2015
Differential Expression of mRNA Encoding
Cytokines and Chemokines in the Reproductive
Tract after Infection of Mice with Chlamydia
trachomatis
Katheryn L. Cerny
University of Kentucky, katheryn.cerny@gmail.com
Maranda Van Fleet
University of Kentucky, maranda.vanfleet@uky.edu
Anatoly Slepenkin
University of California - Irvine
Ellena M. Peterson
University of California - Irvine
Phillip J. Bridges
University of Kentucky, phillip.bridges@uky.edu
Click here to let us know how access to this document benefits you.Follow this and additional works at: https://uknowledge.uky.edu/animalsci_facpub
Part of the Animal Sciences Commons, Food Science Commons, and the Reproductive and
Urinary Physiology Commons
This Article is brought to you for free and open access by the Animal and Food Sciences at UKnowledge. It has been accepted for inclusion in Animal
and Food Sciences Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact
UKnowledge@lsv.uky.edu.
Repository Citation
Cerny, Katheryn L.; Van Fleet, Maranda; Slepenkin, Anatoly; Peterson, Ellena M.; and Bridges, Phillip J., "Differential Expression of
mRNA Encoding Cytokines and Chemokines in the Reproductive Tract after Infection of Mice with Chlamydia trachomatis" (2015).
Animal and Food Sciences Faculty Publications. 9.
https://uknowledge.uky.edu/animalsci_facpub/9
Differential Expression of mRNA Encoding Cytokines and Chemokines in the Reproductive Tract after Infection
of Mice with Chlamydia trachomatis
Notes/Citation Information
Published in Reproductive System & Sexual Disorders: Current Research, v. 4, issue 3, 1000152, p. 1-8.
© 2015 Cerny KL, et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Digital Object Identifier (DOI)
https://doi.org/10.4172/2161-038X.1000152
This article is available at UKnowledge: https://uknowledge.uky.edu/animalsci_facpub/9
Differential Expression of mRNA Encoding Cytokines and Chemokines in the
Reproductive Tract after Infection of Mice with Chlamydia trachomatis
Katheryn L. Cerny1, Maranda Van Fleet1, Anatoly Slepenkin2, Ellena M. Peterson2 and Phillip J. Bridges1*
1Department of Animal and Food Sciences, University of Kentucky, Lexington, KY, USA
2Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA, USA
*Corresponding author: Bridges PJ, Ph.D, Department of Animal and Food Sciences, University of Kentucky, Lexington KY, USA, Tel: 859 257 4877; Fax: 859 257
5318; E-mail: phillip.bridges@uky.edu
Rec date: Aug 06, 2015; Acc date: Sep 02, 2015; Pub date: Sep 09, 2015
Copyright: © 2015 Cerny KL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Infection with Chlamydia trachomatis targets epithelial cells within the genital tract which respond by secreting
chemokines and cytokines. Persistent inflammation can lead to fibrosis, tubal infertility and/or ectopic pregnancy;
many infections are asymptomatic. Most studies have investigated the inflammatory response in the initial stages of
infection, less is known about the later stages of infection, especially with a low, potentially asymptomatic, bacterial
load. Our objective was to determine the inflammatory mediators involved in clearance of low-grade infection and
the potential involvement in chronic inflammation. Six to eight week old C3H/HeJ mice were pretreated with 2.5 mg
medroxyprogesterone acetate on day -10 and -3 before infection. Mice (n=3 for 28 d, n=3 for 35 d) were infected
with 5 × 102 inclusion-forming units of C. trachomatis, serovar D; vaginal cultures were obtained weekly to monitor
infection. Control mice (n=3 for 28 d, n=3 for 35 d) were sham infected. Mice were killed on day 28 (experiment 1)
and day 35 (experiment 2) post-infection and vaginal tissue, uterine horns and oviducts collected for analysis of
mRNAs encoding inflammatory cytokines and chemokines. Total RNA was isolated and a superarray analysis
performed using mouse Cytokines and Chemokines PCR arrays (Qiagen, Valencia, CA). Statistical differences in
gene expression were determined using a paired Students t-test. At 28 days after infection, the expression of mRNA
encoding 6, 35 and 3 inflammatory genes differed from controls in vaginal, uterine and oviductal tissues, respectively
(P<0.05). At 35 days after infection, the expression of mRNA encoding 16, 38 and 14 inflammatory genes differed
from controls in vaginal, uterine and oviductal tissues, respectively (P<0.05). Understanding the mechanisms
involved in the inflammatory response at later stages of infection should aid in the development of treatment options
that minimize the development of asymptomatic, chronic inflammation-induced infertility.
Keywords: Chlamydia trachomatis; Oviduct; Inflammation;
Cytokines; Chemokines; Immune response
Introduction
Chlamydia trachomatis is an obligate intracellular pathogen and the
most frequently reported sexually transmitted bacteria in the United
States [1]. C. trachomatis targets epithelial cells within the genital tract
initiating an immune response. Infectious load is correlated to clinical
pathogenesis [2,3]; infection with C. trachomatis is often
asymptomatic. If left untreated the bacteria can ascend to and infect
the oviducts [4,5]. Untreated C. trachomatis infection can lead to
persistent or recurrent inflammation, fibrosis, scarring, pelvic
inflammatory disease (PID), tubal infertility, and/or an increased
susceptibility to ectopic pregnancy [6,7].
Upon infection, C. trachomatis elementary bodies (EBs) invade host
epithelial cells in the genital tract. Within the host cells, EBs
differentiate into reticulate bodies (RBs) which actively replicate within
the host cell cytoplasm and then reorganize back into infectious EBs.
This biphasic life cycle as well as adaptation to evade the immune
response allows C. trachomatis to persist for extended periods within
host epithelial cells, inducing a chronic inflammatory response [8-12].
Previous studies have investigated the inflammatory response of C.
trachomatis in the initial stages of infection, including regulation by
cytokines, chemokines and inflammatory mediators involved in the
recruitment of immune cells [5,8,10,13,14]. For example, Rasmussen et
al. [10] demonstrated that once C. trachomatis has established
infection within epithelial cells, the innate immune response allows for
the production of pro-inflammatory cytokines such as interleukins 1,
6, 8 (Il-1, Il-6, Il-8), tumor necrosis factor-alpha (TNF-α), and colony
stimulating factor 2 (CSF 2). Secretion of these cytokines and
chemokines recruit immune cells such as natural killer (NK) cells and
phagocytes. Following an established intracellular infection, the T-cell
mediated immune response then becomes the critical element required
for clearance [15]. However, evidence suggests that this T-cell response
also contributes to the pathology following infection. Th1 cells limit
replication of C. trachomatis, but Th2 cells inhibit Th1 responses
leading to continued production of pro-inflammatory cytokines which
can lead to fibrosis [16]. C. trachomatis also induces production of
TNF-α, which promotes apoptosis of infected and bystander cells [17].
Overall, understanding cytokine and chemokine regulation during
both acute and chronic phases of infection may contribute to the
development of treatment options that will minimize the long-term
inflammatory consequences attributed to this disease.
Limited investigation of the overall inflammatory response during
the later stages of infection has been performed, especially after
infection with a low bacterial load. For example, Maxion and Kelly [5]
used 107 IFUs of the mouse pneumonitis biovar of C. trachomatis and
reported that cytokine and chemokine expression differs in
anatomically distinct regions of the genital tract. Specifically, these
authors investigated the expression of chemokines associated with Th1
Reproductive System & Sexual
Disorders: Current Research Cerny et al., Reprod Syst Sex Disord 2015, 4:3http://dx.doi.org/10.4172/2161-038X.1000152
Research Article Open Access
Reprod Syst Sex Disord
ISSN:2161-038X RSSD, an open access journal
Volume 4 • Issue 3 • 1000152
and Th2 responses in the oviducts and cervical-vaginal regions of the
reproductive tract during the induction phase (0-14 days) and
resolution phase (14-35 days) of infection. Our objective was to
determine within the reproductive tract the concurrent level of
expression of mRNA encoding inflammatory mediators during the
later phases of infection using a relatively low infectious load of C.
trachomatis biovar, serovar D, one of the most prevalent serovars
involved in urogenital infections of humans [18]. Two separate
experiments were performed, with tissues collected at 4 and 5 weeks
after infection (experiment 1 and 2, respectively). Our hypothesis was
that mRNA encoding pro-inflammatory cytokines and chemokines
will be differentially expressed in the female reproductive tract of mice
infected with C. trachomatis at both 28 and 35 days post-infection
compared to controls.
Materials and Methods
Ethics statement
All animal experiments were performed according to the guidelines
and protocol approved by the University of California Irvine
Institutional Animal Care and Use Committee (protocol # 2009-2868).
Animal model
Using a previously described model of confirmed genital infection
by C. trachomatis, serovar D, female C3H/HeJ mice, 6- to 8-week old,
(Jackson Laboratories, Sacramento, CA) were pretreated with 2.5 mg
medroxyprogesterone acetate (SICOR Pharmaceuticals) on Days -10
and -3 before infection [19,20]. In both experiments mice were
infected via vaginal challenge with 5 × 102 inclusion-forming units
(IFUs) of C. trachomatis, serovar D in 0.01 mL of Eagle Minimal
essential media (MEM, Gibco) on Day 0, as previously described
[19,20]. Control mice were also pretreated with medroxyprogesterone
acetate, but were sham infected with Eagle Minimal essential media
(MEM, Gibco) alone. Vaginal swabs were obtained twice weekly after
infection and cell cultures were performed to monitor infection as
previously described [19-21].
Mice were killed on day 28 (n=3 for control and infected) in
experiment 1 and day 35 (n=3 for control and infected) in experiment
2. Immediately before being sacrificed vaginal cultures were obtained
and all mice inoculated vaginally with C. trachomatis remained culture
positive but at a significantly lower level than that obtained throughout
the first two weeks of infection. Results of vaginal cultures following
infection with this strain/dose of C. trachomatis, serovar D have been
reported, including number of IFUs recovered [20]. Vaginal tissue,
uterine horns and the oviducts were collected and snap-frozen for later
extraction of RNA.
Isolation of RNA and gene expression analysis
Total RNA was extracted from each tissue sample using TRIzol
reagent (Invitrogen, Carlsbad, CA) and purified through RNeasy
columns (Qiagen, Valencia, CA). To determine the effect of treatment
on the expression of genes involved in the inflammatory response, a
targeted real time PCR SuperArray analysis was performed using RT2
Profiler PCR arrays for mouse Cytokines and Chemokines (Qiagen), as
previously described [22]. Real-time PCR were performed on an
Eppendorf Mastercycler ep realplex2 system (Eppendorf, Hamburg,
Germany).
Gene expression was standardized against GAPDH as a
housekeeping gene and analyzed by the 2−ΔΔCT method [23].
Statistical differences in the expression of mRNA were determined
using a paired Students t-test.
Results
Experiment 1: Expression of mRNA encoding inflammatory
genes in vaginal, uterine and oviduct tissues at 28 days post-
infection
Gene expression analysis was used to determine the effect of
infection on the expression of inflammatory mRNAs at 28 days post-
infection. In vaginal tissue collected at 28 days after infection, the
expression of mRNA encoding 6 inflammatory genes increased and no
genes decreased when compared to controls (Table 1).
28 Day infected vs. control
Gene Symbol
Control Avg. ∆C+
SEM
Infected Avg.
∆C+ SEM
Fold change p‐value
Ccl24 12.79 ± 0.76 10.62 ± 0.53 4.5 0.007
Ccl3 10.18 ± 0.54 7.81 ± 1.00 5.5 0.025
Ccl4 9.03 ± 0.59 6.28 ± 0.44 6.7 0.036
Cd40lg 14.01 ± 0.30 11.05 ± 0.36 7.8 0.011
Cxcl1 9.00 ± 0.25 6.18 ± 0.24 7.1 0.028
Il22 15.96 ± 0.37 15.03 ± 0.39 1.9 0.024
35 day infected vs. control 
Bmp7 6.43 ± 0.17 6.51 ± 0.25 0.5 0.032
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Csf3 4.88 ± 0.05 5.47 ± 0.06 0.5 <0.001
Ccl4 9.03 ± 0.58 6.28 ± 0.23 4.2 0.019
Ctf1 6.67 ± 0.15 7.19 ± 0.12 0.6 0.023
Hprt 1.65 ± 0.14 1.81 ± 0.04 0.6 0.022
Ifna2 11.3 ± 0.19 11.41 ± 0.24 0.4 0.014
Ifng 13.04 ± 0.54 9.68 ± 0.43 8.5 0.035
Il10 9.94 ± 0.38 8.35 ± 0.32 2.8 0.048
Il11 11.76 ± 0.07 10.52 ± 0.23 2.3 0.03
Il18 5.86 ± 0.22 6.54 ± 0.06 0.4 0.014
Il1a 7.13 ± 0.09 5.97 ± 0.04 1.4 0.007
Il1rn 6.36 ± 0.37 5.95 ± 0.13 1.9 0.042
Mif 0.43 ± 0.12 0.76 ± 0.08 0.7 0.045
Pf4 5.15 ± 0.19 5.26 ± 0.06 0.6 0.031
Thpo 12.95 ± 0.6 13.76 ± 0.16 3.7 0.019
Tnf 8.4 ± 0.19 6.86 ± 0.09 2.4 0.002
Table 1: Effect of treatment on the expression of mRNAs in the vagina at 28 and 35 days post‐infection. The normalized average ∆C+ value was
calculated using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold
change (2‐(average Ct)) for differentially expressed mRNAs (P<0.05).
In uterine samples collected at 28 days after infection, the
expression of mRNA encoding 32 inflammatory genes increased and 3
genes decreased when compared to controls (Table 2).
28 Day infected vs. control
Gene
Symbol
Control Avg. ∆C
+ SEM
Infected Avg. ∆C+
SEM
Fold
Change
p-value Gene Symbol Control Avg. ∆C+
SEM
Infected Avg. ∆C+
SEM
Fold
Change
p‐value
Ccl1 13.84 ± 0.32 12.03 ± 0.32 3.5 0.04 Il16 7.41 ± 0.17 6.24 ± 0.27 2.2 0.045
Ccl17 9.56 ± 0.11 7.76 ± 0.21 3.5 0.009 Il27 11.83 ± 0.11 9.70 ± 0.15 4.4 0.002
Ccl2 7.31 ± 0.29 4.53 ± 0.35 6.8 0.025 Lta 11.01 ± 0.21 9.01 ± 0.37 4 0.037
Ccl22 9.18 ± 0.13 7.45 ± 0.31 3.3 0.025 Ltb 6.85 ± 0.16 3.58 ± 0.29 9.6 0.009
Ccl24 11.64 ± 0.13 12.81 ± 0.30 0.4 0.018 Tgfb2 0.67 ± 0.04 2.57 ± 0.76 0.3 0.03
Ccl3 11.52 ± 0.34 8.49 ± 0.13 8.2 0.001 Tnf 9.77 ± 0.22 6.93 ± 0.30 7.2 0.013
Ccl4 9.73 ± 0.39 6.41 ± 0.15 10 0.001 Tnfsf11 10.44 ± 0.47 8.68 ± 0.28 3.4 0.029
Ccl5 5.80 ± 0.05 1.75 ± 0.27 16.6 0.008 Xcl1 7.00 ± 0.19 5.29 ± 0.23 3.3 0.016
Cd40lg 14.40 ± 0.61 8.19 ± 0.35 74 0.016 Ccl12 7.01 ± 0.25 3.70 ± 0.30 9.9 0.015
Csf2 12.12 ± 0.45 9.31 ± 0.17 7 0.002 Ccl7 6.68 ± 0.33 3.63 ± 0.36 8.3 0.027
Cxcl10 8.91 ± 0.06 4.99 ± 0.31 15.1 0.012 Cxcl5 10.50 ± 0.10 5.42 ± 0.46 34 0.049
Cxcl13 7.80 ± 0.73 4.10 ± 0.13 13 0.001 Gusb 2.88 ± 0.09 2.27 ± 0.15 1.5 0.035
Cxcl16 5.19 ± 0.15 3.27 ± 0.20 3.8 0.008 Il12a 12.98 ± 0.35 11.79 ± 0.26 2.3 0.045
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Cxcl9 8.26 ± 0.21 2.47 ± 0.18 55.3 0.001 Il18 6.87 ± 0.06 5.92 ± 0.11 1.9 0.003
Fasl 10.13 ± 0.21 6.46 ± 0.20 12.8 0.002 Il1b 8.29 ± 0.52 5.55 ± 0.33 6.7 0.023
Ifna2 11.25 ± 0.08 12.23 ± 0.38 0.5 0.041 Osm 10.42 ± 0.13 8.05 ± 0.13 5.2 0.001
Ifng 11.30 ± 0.08 7.21 ± 0.28 17.1 0.006 Tnfsf10 5.96 ± 0.13 4.12 ± 0.29 3.6 0.02
Il12b 10.68 ± 0.24 8.07 ± 0.26 6.1 0.007
Table 2: Effect of treatment on the expression of mRNAs in the uterus at 28 days post‐infection. The normalized average ∆C+ value was calculated
using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold change (2-
(average Ct)) for differentially expressed mRNAs (P<0.05).
Of the 6 inflammatory mRNAs that increased within vaginal tissue
after infection, 4 were also differentially affected by treatment in
uterine samples. In oviducts collected at 28 days post-infection, the
expression of mRNA encoding 2 inflammatory genes increased and 1
gene decreased. Of the 3 inflammatory genes affected by treatment
within the oviduct, mRNA encoding 1 gene, chemokine (c-c motif)
ligand 12 (Ccl12), was also increased in uterine samples.
Experiment 2: Expression of mRNA encoding inflammatory
genes in vaginal, uterine and oviduct tissues at 35 days post-
infection
In vaginal tissue collected 35 days after infection, the expression of
mRNA encoding 8 inflammatory genes was increased and 8 decreased
when compared to controls (Table 1). In uterine samples collected at
35 days after infection, the expression of mRNA encoding 32
inflammatory genes increased and 6 genes decreased compared to
controls (Table 3).
35 day infected vs. control
Gene Symbol Control Avg.∆C+ SEM
Infected Avg.
∆C+ SEM Fold change p‐Value Gene symbol
control Avg.
∆C+ SEM
Infected Avg.
∆C+ SEM Fold change p‐value
Ccl1 13.26 ± 0.25 11.66 ± 0.25 3 0.016 Il27 12.87 ± 0.30 9.73 ± 0.27 8.8 0.012
Ccl17 9.41 ± 0.15 7.97 ± 0.34 2.7 0.041 Lta 10.67 ± 0.19 9.22 ± 0.05 2.7 <0.001
Ccl2 6.72 ± 0.14 5.44 ± 0.17 2.4 0.007 Ltb 6.92 ± 0.19 4.28 ± 0.09 6.2 <0.001
Ccl22 8.69 ± 0.15 7.22 ± 0.15 2.8 0.005 Tgfb2 1.26 ± 0.14 3.70 ± 1.24 0.2 0.021
Ccl24 11.25 ± 0.08 13.93 ± 0.94 0.2 0.012 Tnf 9.73 ± 0.09 6.98 ± 0.28 6.7 0.013
Ccl3 10.83 ± 0.31 8.35 ± 0.08 5.6 <0.001 Tnfsf11 9.94 ± 0.12 9.06 ± 0.14 1.8 0.013
Ccl4 9.08 ± 0.23 6.26 ± 0.04 7 <0.001 Xcl1 7.12 ± 0.19 5.41 ± 0.40 3.3 0.05
Ccl5 5.47 ± 0.21 2.32 ± 0.09 8.9 <0.001 Adipoq 11.58 ± 1.29 6.81 ± 0.40 27.2 0.034
Cd40lg 13.94 ± 0.93 8.64 ± 0.16 39.4 0.001 Cd70 11.19 ± 0.19 10.38 ± 0.07 1.7 0.008
Csf2 11.51 ± 0.29 8.78 ± 0.16 6.6 0.002 Cntf 7.99 ± 0.08 8.62 ± 0.17 0.6 0.023
Cxcl10 9.18 ± 0.19 5.08 ± 0.27 17.1 0.005 Csf3 7.55 ± 0.15 6.56 ± 0.18 2 0.017
Cxcl13 8.83 ± 0.27 4.51 ± 0.36 20 0.017 Cxcl1 11.41 ± 0.43 7.49 ± 0.46 15.1 0.029
Cxcl16 5.00 ± 0.23 3.14 ± 0.13 3.6 0.002 Cxcl11 12.94 ± 0.27 6.26 ± 0.34 102.5 0.018
Cxcl9 8.06 ± 0.22 2.41 ± 0.26 50.3 0.006 Il10 11.18 ± 0.41 8.77 ± 0.15 5.3 0.003
Fasl 10.25 ± 0.04 6.92 ± 0.29 10.1 0.013 Il21 15.24 ± 0.15 10.55 ± 0.46 25.8 0.047
Ifna2 10.87 ± 0.31 12.36 ± 0.33 0.4 0.037 Il3 15.11 ± 0.11 14.13 ± 0.22 2 0.026
Ifng 10.76 ± 0.16 7.33 ± 0.09 10.8 <0.001 Thpo 11.89 ± 0.16 13.27 ± 0.36 0.4 0.02
Il12b 10.31 ± 0.23 8.46 ± 0.12 3.6 0.002 Tnfsf10 5.82 ± 0.18 3.80 ± 0.19 4 0.004
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Il16 7.75 ± 0.11 6.75 ± 0.20 2 0.02 Vegfa 4.23 ± 0.13 4.83 ± 0.09 0.7 0.023
Table 3: Effect of treatment on the expression of mRNAs in the uterus at 35 days post‐infection. The normalized average ∆C+ value was calculated
using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold change (2‐
(average Ct)) for differentially expressed mRNAs (P<0.05).
Of the 16 inflammatory mRNAs affected by treatment in vaginal
tissue, 7 were also differentially expressed in uterine samples and 3 in
oviduct samples. In oviducts collected at 35 days post infection, the
expression of mRNA encoding 13 inflammatory genes was increased
and 1 gene decreased (Table 4).
28 Day infected vs. control
Gene Symbol Control Avg. ∆C+ SEM Infected Avg. ∆C+ SEM Fold change p‐value
Ccl12 6.81 ± 0.37 4.39 ± 0.51 5.3 0.045
Il13 10.45 ± 0.21 11.69 ± 0.28 0.4 0.029
Il23a 11.43 ± 0.10 10.96 ± 0.08 1.4 0.021
35 Day infected vs. control
Bmp7 7.97 ± 0.21 6.99 ± 0.12 2 0.011
Ccl17 7.11 ± 0.52 6.19 ± 0.32 6.1 0.021
Cd40lg 13.02 ± 0.30 10.40 ± 0.36 6.2 0.03
Cx3cl1 5.16 ± 0.21 4.16 ± 0.18 2 0.025
Cxcl1 12.57 ± 0.25 9.99 ± 0.24 6 0.007
Fasl 12.75 ± 0.66 8.79 ± 0.34 15.6 0.019
Gpi1 2.71 ± 0.04 1.56 ± 0.26 2.2 0.039
Hsp90ab1 0.53 ± 0.18 1.98 ± 0.26 2.7 0.027
Il12b 13.10 ± 0.24 10.47 ± 0.17 6.2 0.003
Il1a 11.42 ± 0.22 9.65 ± 0.23 3.4 0.011
Il9 7.16 ± 0.21 8.21 ± 0.26 0.5 0.044
Lif 10.03 ± 0.38 8.77 ± 0.08 2.4 0.016
Mif 1.55 ± 0.09 0.17 ± 0.29 2.6 0.044
Osm 11.50 ± 0.44 9.93 ± 0.33 3 0.047
Table 4: Effect of treatment on the expression of mRNAs in the oviduct at 28 and 35 days post‐infection. The normalized average ∆C+ value was
calculated using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold
change (2‐(average Ct)) for differentially expressed mRNAs (P<0.05).
Of the 14 inflammatory mRNAs affected by treatment within the
oviduct, 5 were also differentially expressed in uterine samples and 3 in
vaginal tissue.
Discussion
The host response to infection with C. trachomatis includes the
induction of pro inflammatory cytokines and chemokines which leads
to innate and adaptive immune cell recruitment and activation [24].
Although the immune response is critical to the clearance of infection,
the cellular immune response in particular can cause tissue damage
that promotes fibrosis and can lead to infertility [16]. Considering that
infection with C. trachomatis is often asymptomatic, the objective of
these two experiments was to identify inflammatory mediators
induced during the later phases of low-dose C. trachomatis genital
infection in order to advance our understanding of disease progression
and the immune response involved in potentially asymptomatic
chronic inflammation.
It is well known that susceptibility to C. trachomatis infection is
genetically controlled in mice. Both Tuffrey et al. [25-27] and Peterson
et al. [19-21] have shown that human serovars of C. trachomatis can
infect the genital tract of mice, specifically C3H/HeJ mice.
Progesterone pretreatment is necessary, but this strain of mice remains
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culture positive for more than 4 weeks following infection [20]. In the
current study, infected mice continued to have positive vaginal C.
trachomatis cultures for the duration of the experiments with IFUs
lower when the mice were killed compared to the first two weeks of
infection.
In experiment 1, mice were killed 28 days post-infection. In vaginal
tissue, mRNA encoding several cytokines and chemokines was affected
by infection with C. trachomatis. Among differentially-regulated genes
in vaginal samples, the expression of mRNA encoding chemokine (c-c
motif) ligand 4 (Ccl4), also known as macrophage inflammatory
protein-1β (MIP-1β), a potent lymphocyte chemo attractant, was
induced at 28 days of infection, with greater than a 6-fold increase
compared to controls. C-C motif chemokines are a subgroup of
chemokines with two adjacent cysteine residues near the amino
terminus [28]. Yilma et al. [29] reported an increase in Ccl4 production
in mouse macrophages during the early response to C. trachomatis
infection; therefore, our results suggest that this cytokine is actively
involved in both the early response and late phases of infection.
Interestingly, Ccl4 is highly related to macrophage inflammatory
protein-1α (Ccl3) and it is thought that these C-C motif chemokines
are secreted to recruit specific T cell subsets during the immune
response [30,31]. In our study, expression of mRNA encoding Ccl3 in
the vagina was also increased at 28 days post-infection.
Of all the differentially affected mRNAs in vaginal tissue, the largest
fold-change in 28 day infected samples was seen in the induction of
mRNA encoding CD40 ligand (Cd40lg). Cd40lg is mostly found on the
surface of CD4+ T cells and its interaction with Cd40 is required in the
activation of humoral and cellular immune responses [32].
Within the uterus, treatment affected the expression of mRNA for
five C-X-C motif chemokines. C-X-C motif chemokines are a
subgroup of chemokines that have amino terminus cysteine residues
separated by one amino acid [28]. Most notable is the induction of
mRNA encoding chemokine (c-x-c motif) ligand 9 (Cxcl9). Previous
studies have reported that Cxcl9 peaks during the early phases of
infection in the upper genital tract and may be involved in Th1
responses [5], our results suggest that within the uterus, Cxcl9-
mediated inflammation remains ongoing even after the initial phase of
infection. The expression of mRNA encoding several interleukins was
also induced in the infected mouse uterus at 28 days post-infection,
including Il1b, Il12a, Il12b, Il16, Il18, and Il27. Notably, Il12 is also
reported to be involved in Th1 responses [33]. In our results, mRNA
for Il12 subunit alpha (Il12a) and subunit beta (Il12b) was induced at
28 days after infection. Several tumor necrosis factor family members
and interferons were also induced, supporting the hypothesis that
inflammation remains active and ongoing within the uterus during the
late, resolution phase of infection.
When compared to the response observed in vaginal and uterine
tissues at 28 days, the oviduct had fewer mRNA differentially expressed
after infection of mice with C. trachomatis.
The expression of mRNA encoding two genes was increased and
one gene decreased. C. trachomatis-induced cell death within the
oviduct is of concern due to long term sequelae, especially when
considering that upon initial intracellular invasion of epithelial cells, C.
trachomatis has the ability to prevent apoptosis of infected cells,
therefore promoting infection [8,13,14]. Interestingly, the expression of
mRNA encoding fas ligand (TNF superfamily, member 6; Fasl), a key
mediator of apoptosis, was not affected by treatment at 28 days post
infection within the oviduct.
In experiment 2, mice were killed 35 days post-infection. The level
of mRNA encoding 4 interleukins (Il10, Il11, Il1rn, Il1a) was increased
and 1 interleukin (Il18) decreased in vaginal tissue collected at 35 days
post-infection. Of these, Il18 is reported to interact with Il12 to
stimulate interferon gamma (IFN-γ) production from NK cells during
the early host response to infection [34]. Although studies have
reported that IFN-γ is crucial for immune cell responses to C.
trachomatis [34-36], the expression of mRNA for Il12 did not differ at
35 days after infection and there was a decrease in levels of mRNA for
Il18. Furthermore, IFN-γ had the greatest fold change of all
differentially induced mRNA in the infected vaginal tissues, suggesting
that IFN-γ production is being stimulated by other immunoregulatory
factors at this later stage of infection.
The increase in expression of mRNA encoding Il10 within vaginal
samples collected at 35 days after infection was not expected.
Interleukin-10 is considered an anti-inflammatory cytokine and a
recent study using C. trachomatis infected HeLa cells demonstrated
that exogenous Il10 treatment decreased several inflammatory
cytokines including TNF [37,38].
Similar to vaginal tissues, uterine samples collected 35 days post-
infection with C. trachomatis had increased expression of Il10 and
TNF. Furthermore, an increase in adiponectin (Adipoq) was observed.
Similar to Il10, Adipoq has anti-inflammatory properties including
regulating cell defense and survival during stress conditions [39,40]. In
addition, a dramatic increase in the expression of mRNA for Cxcl11
(102-fold change) was observed. Cxcl11 shares features with Cxcl9 and
Cxcl10, including induction by interferons and expression on activated
Th1 cells [41,42]. It is reported that the Th1 response is crucial for
controlling C. trachomatis infection, our results that mRNA for these
transcripts were induced within the infected uterus is therefore
consistent with other studies.
Within the oviduct mRNA encoding 13 genes was increased and one
gene decreased at 35 days after infection. The expression of mRNA
encoding fasl increased at 35 days after infection with a 15-fold-
change. In addition, changes in mRNA for other inflammatory
mediators involved in tissue damage were detected, including Il1-a,
which is released from lysed cells and acts by stimulating further
cytokine release from neighboring cells [10]. Interestingly, levels of
mRNA for Leukemia inhibitory factor (Lif) were increased in 35 day
infected oviducts. Guney et al. [43] demonstrated that LIF expression
is increased in the oviducts of woman with ectopic pregnancies
compared to non-pregnant woman. Furthermore, Ji et al. [44]
proposed that LIF facilitates implantation of the embryo in the oviduct
when the stromal surface is exposed due to epithelial cell shedding
caused by chronic inflammation. The results shown here warrant
further investigation especially since C. trachomatis have the ability to
not only disrupt infected epithelial cells, but also non-infected cells in
proximity to the infection [8]. In oviductal epithelia, these changes in
gene expression and disruption of cellular processes can increase the
risk of chronic inflammation-induced pelvic inflammatory disease and
infertility.
Overall, this study examined the coordinated and concurrent
expression of mRNA encoding multiple cytokines in spatially distinct
sections of the reproductive tract. We investigated the later stages of
infection using a relatively low infectious dose in order to obtain a
better understanding of the genetic mechanisms involved in chronic
inflammation and cellular damage. Differences in the magnitude of
response to infection in differing regions of the reproductive tract were
expected, as were differences in the level of expression of specific
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mRNAs within a tissue over time [5], illustrating well the dynamic
nature of the inflammatory response to infection and the need for
inclusive analyses of inflammatory mediators.
Understanding the mechanisms involved in the inflammatory
response at late stages of infection should aid in the development of
treatment options that minimize chronic inflammation-induced pelvic
inflammatory disease and infertility.
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